September 17, 2025- Thermo Fisher Scientific Inc. introduced the launch of the Olink® Goal 48 Neurodegeneration panelA robust, focused Proteomics Immunoassay panel developed to speed up discoveries in analysis into neurodegenerative ailments. With ailments akin to Alzheimer's, a number of sclerosis and Parkinson's on the rise and medical pipelines which can be smitten by translational biomarkers, researchers are confronted with an pressing want for scalable, reproducible and disease-relevant protein measurement. This panel delivers simultaneous measurement of 41 key and rising proteins for analysis into neurodegeneration with absolute quantification and optimized for plasma measurement from simply 1 µl pattern.

The objective 48 Neurodegeneration panel is the most recent addition to the rising portfolio of Olink of multiplex illness panels with absolute quantification libres. Along with the Olink® goal 48 Cytokine, Olink® Goal 48 Immune Surveillance and the Semi-Customized Olink® Flex platform, this resolution helps to create a strong ecosystem for Proteomics analysis. Together, these panels can seamlessly analyze a bigger library of protein biomarkers that may assist to supply intensive insights into neurodegeneration and irritation within the physique.

Learn extra